Navigation Links
Pharmaxis Appoints French Distributor for Aridol(TM)
Date:3/10/2009

SYDNEY, March 11 /PRNewswire-Asia/ -- Pharmaxis (ASX: PXS; NASDAQ: PXSL) is pleased to announce that it has appointed Praxis Pharmaceutical France SARL as its French marketer and distributer for the asthma diagnostic tool, Aridol.

Praxis Pharmaceutical is a recently established company created to introduce a portfolio of respiratory specialist products into the French pharmaceutical market. Praxis will complete the reimbursement application for Aridol in France and thereafter market the product to hospital specialists.

Dr Alan Robertson, Pharmaxis CEO said "We are delighted to announce this agreement and are looking forward to working with Praxis on developing the French market for Aridol. Aridol is a precisely engineered test that we believe will be an improvement on current practice. Aridol improves the identification of bronchial hyperresponsiveness which is one of the hallmarks of asthma."

The total population affected by Asthma in France is approximately 3.1 million. The French bronchial challenge testing market is dominated by methacholine and more than 25,000 tests are conducted annually with little recent innovation in the field. Aridol's ability to detect airway hyperresponsiveness in poorly controlled asthmatics offers information to the respiratory physician that has previously not been available.

Aridol is approved for sale in most major European countries, Australia and Korea. Aridol has been included in the Global Initiative for Asthma guidelines, and in the U.S. Asthma Management Guidelines. It is one of the tests recommended by the World Anti-Doping Agency, and other sports governing bodies to ensure elite athletes who are asthmatic are properly diagnosed and treated.

Forward-Looking Statements

The statements contained in this media r
'/>"/>

SOURCE Pharmaxis Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharmaxis Builds Senior Management Team
2. Pharmaxis Investor Conference Call
3. Pharmaxis Aridol Approved for Sale in Switzerland
4. Pharmaxis Investor Conference Call
5. Pharmaxis Research Programs Highlighted at European Respiratory Society Congress
6. New Pharmaxis Board Appointment
7. Pharmaxis Aridol Authorised for Sale in Germany
8. Pharmaxis First Steps into China
9. Pharmaxis to Apply to Market Bronchitol in Australia
10. Pharmaxis Investor Conference Call
11. Pharmaxis Aridol Gains First Asian Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2
...euticals,Inc. (the "Company") (Amex: IMM ) is ple...ate communications specialist Blythe Weigh Communi... Company (http://www.blytheweigh.com )., Cecilia...elighted to,have Blythe Weigh join our PR/IR team ... in other key markets.", Founder Tim Blythe has o...
... and Bioanalytical Chemistry (ABC) has chosen the ...recipient of its Best Paper Award 2007. Lummersto...robed with infrared spectroscopy discusses an infr...al importance in various fields of nanoscience. T...n an ABC cover. The Award is accompanied by EUR 1...
...Plans, Technology Leadership, INDIANAPOLIS, Feb. ...es, a wholly owned subsidiary of The Dow Chemical,...tion made to investors,earlier today by Jerome Per...bere was speaking at the Goldman Sachs Agricultura...reinforced Dow AgroSciences,technology-based strat...
Other Biology Technology:Immtech Appoints Blythe Weigh as Strategic Advisor 2Immtech Appoints Blythe Weigh as Strategic Advisor 3Dow AgroSciences' Success Presented to Wall Street 2
(Date:12/3/2009)Have you ever felt overly upset by a social snubbing? Your genetics, not your friends, may be at fault. , Scientists have long known that opium-like painkillers, called opioids, relieve not only phys
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Grooving down the helix 2Grooving down the helix 37 Easy Tips for Healthy Aging 54745 17 Easy Tips for Healthy Aging 54745 2 24750 000 Awarded for Cutting Edge Research to Reduce the Severity of Asthma Attacks 54740 1 24750 000 Awarded for Cutting Edge Research to Reduce the Severity of Asthma Attacks 54740 2SyntheMed Receives Russian Regulatory Approval for REPEL CV 28TM 29 13610 1SyntheMed Receives Russian Regulatory Approval for REPEL CV 28TM 29 13610 2
...linois study have demonstrated an effective way to...s. , Eating two CocoaVia dark chocolate bars a da...ted effect of also lowering systolic blood pressur...science and human nutrition. , The study, funded ...ars, was published in this months Journal of Nutri...
... , Gel-like material shows promise as oral ins...earchers in Texas report development of a gel-like...rrival of insulin that can be taken in a pill by m...heduled for the April 14 issue of ACS Biomacromole...as A. Peppas and colleagues point out acid in the ...
...r young male offspring who suffer a dominant mothe...rden. And all because of follicular testosterone. ...luence on sex determination: dominant human female...on p. 812 of the May issue of Biology of Reproduc...ely correlates with pre-ovulatory follicular testo...
Other Biology News:Chocolate bar shown to lower cholesterol 2American Chemical Society's Weekly PressPac -- April 16, 2008 2American Chemical Society's Weekly PressPac -- April 16, 2008 3American Chemical Society's Weekly PressPac -- April 16, 2008 4American Chemical Society's Weekly PressPac -- April 16, 2008 5American Chemical Society's Weekly PressPac -- April 16, 2008 6American Chemical Society's Weekly PressPac -- April 16, 2008 7American Chemical Society's Weekly PressPac -- April 16, 2008 8Biology of Reproduction highlights 2
Mouse Anti-Human ALPK3 Monoclonal Antibody, Unconjugated, Clone 4G4 from Abnova Corporation
... Cell Lines ,High Quality, Functionally-Validated,...nown for having a critical role in nerve and muscl... pain, CNS and the heart. Drugs that modulate ion ...as, such as neuropathic pain, cardiac arrhythmia, ...
... Cell Lines ,High Quality, Functionally-Validated,...nown for having a critical role in nerve and muscl... pain, CNS and the heart. Drugs that modulate ion ...as, such as neuropathic pain, cardiac arrhythmia, ...
... Cell Lines ,High Quality, Functionally-Validated,...nown for having a critical role in nerve and muscl... pain, CNS and the heart. Drugs that modulate ion ...as, such as neuropathic pain, cardiac arrhythmia, ...
Biology Products: